<< Read Full Article

FDA Approves Inhaled Insulin

Stock quotes in this article: PFE , NKTR , SNY  

Updated from 7:51 a.m. EST

The Food and Drug Administration on Friday gave its approval to Exubera, an inhaled form of insulin developed by Nektar Therapeutics (NKTR Quote) and Pfizer (PFE Quote), a day after the product was also cleared by European regulators.

Exubera, the first inhaled insulin approved for sale, will improve compliance among diabetics who now inject insulin to control blood sugar, the product's manufacturers say. According to the FDA, Exubera is the first new insulin delivery option introduced since insulin's discovery in the 1920s. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,285.97 1,091.93 2,172.99 33.92
Oil *
75.40
DOWN
104.14
DOWN
11.32
DOWN
16.62
DOWN
0.56
10 Yr
3.39%
SPDR Gold
110.95
-1.00%
-1.03%
-0.76%
-1.62%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services